Phathom Pharmaceuticals Inc (PHAT) — Financial Flexibility Index
Phathom Pharmaceuticals Inc (PHAT) has a Financial Flexibility Index of -0.02x as of September 2025. Free cash flow of $-14.09 Million (operating CF $-14.12 Million minus capex $27.00K) represents 0% of total liabilities ($662.82 Million). Also explore PHAT shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Phathom Pharmaceuticals Inc Financial Flexibility Index (2018–2024)
Historical Financial Flexibility Index trend for Phathom Pharmaceuticals Inc across 7 annual periods. Check PHAT capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Phathom Pharmaceuticals Inc (2018–2024)
Year-by-year free cash flow to debt coverage for Phathom Pharmaceuticals Inc. For the full company profile including market capitalisation, see PHAT stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.42x | $-266.63 Million | $-266.77 Million | $631.90 Million | ▼ -51.0% |
| 2023 | -0.28x | $-135.95 Million | $-137.58 Million | $486.60 Million | ▲ +54.0% |
| 2022 | -0.61x | $-145.49 Million | $-146.53 Million | $239.62 Million | ▲ +51.9% |
| 2021 | -1.26x | $-148.13 Million | $-148.46 Million | $117.28 Million | ▼ -85.5% |
| 2020 | -0.68x | $-68.65 Million | $-69.69 Million | $100.84 Million | ▼ -76.7% |
| 2019 | -0.39x | $-11.26 Million | $-36.51 Million | $29.22 Million | ▲ +5.4% |
| 2018 | -0.41x | $-891.00K | $-1.02 Million | $2.19 Million | — |